Relaxo Footwears Limited has informed the Exchange regarding Outcome of Board Meeting held on May 09, 2025.
RELAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Relaxo Footwears reported its FY25 audited results, with annual revenue from operations declining to ₹2,789.61 cr from ₹2,914.06 cr in FY24, a drop of about 4.3%. Profit after tax fell to ₹170.33 cr from ₹200.47 cr, down roughly 15%. Q4 FY25 revenue was ₹695.15 cr versus ₹747.21 cr in Q4 FY24, with Q4 PAT at ₹56.22 cr versus ₹61.39 cr. EBITDA margins compressed by about 120 basis points year-on-year as cost pressures weighed on profitability. The board recommended a final dividend of ₹3 per share (300% of face value), totaling ₹74.68 cr. The statutory auditors M/s Gupta & Dua issued an unmodified opinion on the financial statements, indicating no qualifications or concerns.
Negative for shareholders in the short term — both top-line and bottom-line contracted year-on-year, and margins shrank, though the company remains debt-free with strong operating cash flows of ₹406 cr and a healthy dividend payout. The clean audit report and zero borrowings provide stability, but the topline decline signals demand or pricing pressure that investors will watch closely.